Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-05 Sale | 2024-03-07 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 4,135 | $18.73 | $77,440 | 3,023,002 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 4,135 | $18.73 | $77,440 | 2,959,308 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 1,792 | $18.73 | $33,560 | 161,315 (Indirect Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:05 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 1,540 | $18.73 | $28,841 | 81,372 (Direct) | View |
| 2024-02-23 Sale | 2024-02-27 5:59 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 2,838 | $18.76 | $53,231 | 46,245 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:11 pm | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 5,841 | $16.33 | $95,372 | 2,836,776 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:11 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 2,716 | $16.33 | $44,347 | 123,107 (Indirect Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:10 pm | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 5,841 | $16.33 | $95,372 | 2,900,470 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 5:04 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 2,812 | $16.33 | $45,915 | 205,605 (Direct) | View |
| 2023-12-15 Purchase | 2023-12-19 4:37 pm | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 4,000 | $14.97 | $59,880 | 5,000 (Direct) | View |
| 2023-08-15 Sale | 2023-08-17 4:35 pm | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 6,164 | $20.88 | $128,686 | 49,083 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 8:54 pm | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $26.94 | $875,451 | 457,158 (Indirect Direct) | View |
| 2023-05-15 Sale | 2023-05-17 4:58 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 11,965 | $29.03 | $347,358 | 257,591 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-16 Option Award | 2024-04-18 8:23 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 211,180 | $0 | 372,495 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:21 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 559,850 | $0 | 3,582,852 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:20 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 190,560 | $0 | 271,932 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:20 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 559,850 | $0 | 3,519,158 (Direct) | View |
| 2024-04-16 Option Award | 2024-04-18 8:19 pm | N/A 2034-04-15 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 216,910 | $0 | 275,243 (Direct) | View |
| 2024-03-14 Option Award | 2024-03-15 4:35 pm | N/A 2034-03-13 | Amylyx Pharmaceuticals Inc. | AMLX | Zeiher Bernhardt G Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-28 6:44 pm | N/A 2034-02-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 100,000 | $0 | 223,107 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-28 6:22 pm | N/A 2034-02-25 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 316,667 | $0 | 3,217,137 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-28 6:20 pm | N/A 2034-02-25 | Amylyx Pharmaceuticals Inc. | AMLX | Klee Justin B. Co-Chief Executive Officer | 316,667 | $0 | 3,153,443 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-28 6:13 pm | N/A 2034-02-25 | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 91,667 | $0 | 137,912 (Direct) | View |
| 2024-01-25 Gift | 2024-01-29 4:38 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 9,100 | $0 | 758,571 (Direct) | View |
| 2024-01-16 Gift | 2024-01-18 4:50 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 94,350 | $0 | 767,671 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 4:07 pm | N/A 2029-05-13 | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 25,000 | $0 | 320,685 (Direct) | View |
| 2023-12-27 Exercise | 2023-12-29 4:07 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 25,000 | $0.37 | 320,685 (Direct) | View |
| 2023-11-27 Option Award | 2023-11-29 4:49 pm | N/A 2033-11-26 | Amylyx Pharmaceuticals Inc. | AMLX | Bedrosian Camille L Chief Medical Officer | 220,833 | $0 | 220,833 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 8:20 pm | N/A 2025-02-26 | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 63,694 | $0 | 2,942,617 (Direct) | View |
| 2023-11-16 Exercise | 2023-11-20 8:20 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Cohen Joshua B Co-Chief Executive Officer | 63,694 | $1.57 | 2,942,617 (Direct) | View |
| 2023-10-31 Gift | 2023-11-02 3:33 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 11,072 | $0 | 125,823 (Indirect) | View |
| 2023-08-23 Exercise | 2023-08-24 4:15 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $0 | 489,658 (Direct) | View |
| 2023-08-23 Exercise | 2023-08-24 4:15 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 18,165 | $6.88 | 489,658 (Direct) | View |
| 2023-08-15 Gift | 2023-08-17 5:34 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Morningside Venture Investments Ltd 10% Owner | 2,000,000 | $0 | 4,997,302 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 4:20 pm | N/A 2029-05-13 | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 20,000 | $0 | 320,685 (Direct) | View |
| 2023-07-12 Exercise | 2023-07-14 4:20 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 20,000 | $0.37 | 320,685 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 7:50 pm | N/A 2033-06-08 | Amylyx Pharmaceuticals Inc. | AMLX | Firestone Karen Director | 3,908 | $0 | 3,908 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 7:46 pm | N/A 2033-06-08 | Amylyx Pharmaceuticals Inc. | AMLX | MILNE GEORGE M JR Director | 16,985 | $0 | 16,985 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 7:39 pm | N/A 2033-06-08 | Amylyx Pharmaceuticals Inc. | AMLX | Quimi Daphne Director | 16,985 | $0 | 16,985 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 7:34 pm | N/A 2033-06-08 | Amylyx Pharmaceuticals Inc. | AMLX | FONTEYNE PAUL R. Director | 16,985 | $0 | 16,985 (Direct) | View |
| 2023-05-22 Gift | 2023-05-24 4:38 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Olinger Margaret Chief Commercial Officer | 1,580 | $0 | 231,108 (Direct) | View |
| 2023-05-17 Gift | 2023-05-19 4:07 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Mazzariello Gina Chief Legal Officer | 500 | $0 | 55,247 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 8:54 pm | N/A 2031-01-25 | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $0 | 457,158 (Direct) | View |
| 2023-05-16 Exercise | 2023-05-18 8:54 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | FRATES JAMES M Chief Financial Officer | 32,500 | $6.88 | 457,158 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 4:58 pm | N/A 2029-03-18 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 11,965 | $0 | 257,591 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 4:58 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 2,201 | $0.37 | 257,591 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 4:58 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 9,764 | $6.88 | 257,591 (Direct) | View |